Terms: = Leukemia AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Clinical Outcome
15 results:
1. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.
Dürr C; Hanna BS; Schulz A; Lucas F; Zucknick M; Benner A; Clear A; Ohl S; Öztürk S; Zenz T; Stilgenbauer S; Li-Weber M; Krammer PH; Gribben JG; Lichter P; Seiffert M
Haematologica; 2018 Apr; 103(4):688-697. PubMed ID: 29326123
[TBL] [Abstract] [Full Text] [Related]
2. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract] [Full Text] [Related]
4. T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.
Li H; Yan X; Liu L; Huang L; Yin M; Pan C; Zhang P; Qin H
Biomed Pharmacother; 2017 Apr; 88():924-930. PubMed ID: 28178623
[TBL] [Abstract] [Full Text] [Related]
5. Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.
Liu J; Chen G; Pelicano H; Liao J; Huang J; Feng L; Keating MJ; Huang P
Oncotarget; 2016 Nov; 7(44):71378-71389. PubMed ID: 27655686
[TBL] [Abstract] [Full Text] [Related]
6. Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53.
Ogasawara MA; Liu J; Pelicano H; Hammoudi N; Croce CM; Keating MJ; Huang P
Mitochondrion; 2016 Nov; 31():33-39. PubMed ID: 27650502
[TBL] [Abstract] [Full Text] [Related]
7. The regulatory interaction of EVI1 with the tcl1a oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract] [Full Text] [Related]
8. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.
Shahjahani M; Mohammadiasl J; Noroozi F; Seghatoleslami M; Shahrabi S; Saba F; Saki N
Cell Oncol (Dordr); 2015 Apr; 38(2):93-109. PubMed ID: 25563586
[TBL] [Abstract] [Full Text] [Related]
9. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.
Kaderi MA; Kanduri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Jurlander J; Juliusson G; Mansouri L; Rosenquist R
Haematologica; 2011 Aug; 96(8):1153-60. PubMed ID: 21508119
[TBL] [Abstract] [Full Text] [Related]
10. Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.
Zucchetto A; Cattarossi I; Nanni P; Zaina E; Prato G; Gilestro M; Marconi D; Bulian P; Rossi FM; Del Vecchio L; Omedè P; Geuna M; Del Poeta G; Gattei V
Immunol Lett; 2011 Jan; 134(2):137-44. PubMed ID: 20923685
[TBL] [Abstract] [Full Text] [Related]
11. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer SW; Piñón JD; Brachtl G; Haginger L; Wang W; Jöhrer K; Tinhofer I; Hartmann TN; Greil R
Cancer Res; 2010 Sep; 70(18):7336-44. PubMed ID: 20823161
[TBL] [Abstract] [Full Text] [Related]
12. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract] [Full Text] [Related]
13. IGHV3-21 gene usage is associated with high tcl1 expression in chronic lymphocytic leukemia.
Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
[TBL] [Abstract] [Full Text] [Related]
14. High tcl1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.
Herling M; Patel KA; Weit N; Lilienthal N; Hallek M; Keating MJ; Jones D
Blood; 2009 Nov; 114(21):4675-86. PubMed ID: 19770358
[TBL] [Abstract] [Full Text] [Related]
15. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories.
Herling M; Khoury JD; Washington LT; Duvic M; Keating MJ; Jones D
Blood; 2004 Jul; 104(2):328-35. PubMed ID: 15044256
[TBL] [Abstract] [Full Text] [Related]